Trials / Completed
CompletedNCT04249310
Early Intervention Efficacy in COPD
Early Intervention Effectiveness of Tiotropium / Olodaterol Compared to Tiotropium in COPD
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 6,788 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the time to escalation to triple therapy among the Japanese Chronic obstructive pulmonary disease (COPD) patients newly initiating therapy with a combination of Olodaterol and Tiotropium (herein referred to as Tio/Olo) using real world data.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tiotropium/Olodaterol | Soft Mist Inhaler product |
| DRUG | Tiotropium | Soft Mist Inhaler product |
Timeline
- Start date
- 2020-03-27
- Primary completion
- 2020-08-12
- Completion
- 2020-08-12
- First posted
- 2020-01-30
- Last updated
- 2022-06-14
- Results posted
- 2021-08-30
Locations
1 site across 1 country: Japan
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04249310. Inclusion in this directory is not an endorsement.